Pathogen load and species monitored by droplet digital PCR in patients with bloodstream infections: A prospective case series study

[1] Munoz P(2008)Gram-negative bloodstream infections Int J Antimicrob Agents 32 10-4

[2] Cruz AF(2010)Hospital-acquired infections due to gram-negative bacteria N Engl J Med 362 1804-13

[3] Rodriguez-Creixems M(2012)Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study Intensive Care Med 38 1930-45

[4] Bouza E(2017)Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy J Infect 74 131-41

[5] Peleg AY(2019)Rationalizing antimicrobial therapy in the ICU: a narrative review Intensive Care Med 45 172-89

[6] Hooper DC(2016)Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis Clin Microbiol Rev 29 59-103

[7] Tabah A(2018)A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections Eur J Clin Microbiol Infect Dis 37 167-73

[8] Koulenti D(2017)Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Intensive Care Med 43 304-77

[9] Laupland K(2020)Bloodstream infections in critically ill patients: an expert statement Intensive Care Med 46 266-84

[10] Misset B(2019)Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic Study Ann Intern Med 171 547-54

[1] Munoz P(2008)Gram-negative bloodstream infections Int J Antimicrob Agents 32 10-4

[2] Cruz AF(2010)Hospital-acquired infections due to gram-negative bacteria N Engl J Med 362 1804-13

[3] Rodriguez-Creixems M(2012)Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study Intensive Care Med 38 1930-45

[4] Bouza E(2017)Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy J Infect 74 131-41

[5] Peleg AY(2019)Rationalizing antimicrobial therapy in the ICU: a narrative review Intensive Care Med 45 172-89

[6] Hooper DC(2016)Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis Clin Microbiol Rev 29 59-103

[7] Tabah A(2018)A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections Eur J Clin Microbiol Infect Dis 37 167-73

[8] Koulenti D(2017)Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Intensive Care Med 43 304-77

[9] Laupland K(2020)Bloodstream infections in critically ill patients: an expert statement Intensive Care Med 46 266-84

[10] Misset B(2019)Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic Study Ann Intern Med 171 547-54